|
|
| Research article summary (published 9 May 2009): |
Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses.
Full Abstract
BACKGROUND: The immunological mechanisms responsible for the immunomodulatory and anti-allergic effects of probiotic bacteria are still poorly defined. The combined effects of mixtures of different species of probiotic bacteria have been explored only in part. The present study describes the immunomodulatory activity of the VSL#3 probiotic preparation in in vitro and in vivo systems. METHODS: The activation and cytokine production by in vitro probiotic-stimulated bone-marrow dendritic cells (BM-DCs) and spleen cells isolated from naïve or Par j 1-sensitized mice were investigated. Mice were intranasally administered a sonicate preparation of VSL#3 before immunization with rPar j 1. Serum antibody levels and cytokine expression in the lung were determined. RESULTS: Both live and sonicated VSL#3 preparations induced maturation and cytokine production by BM-DCs. Cytokine production by spleen cells from naïve or Par j 1-sensitized mice was modulated by the probiotic preparations towards a Treg/Th0 profile, characterized by increased IL-10 and IFN-gamma production. In vivo prophylactic treatment with VSL#3 induced a significant reduction of serum specific IgG1. At lung level, VSL#3 pre-treatment remarkably reduced IL-13 and IL-4 mRNA expression and increased IL-10 expression. CONCLUSIONS: The VSL#3 preparations have not only the capacity to bias primary immune responses towards a Treg/Th0-type profile, but also to modify in the same way the functional characteristics of established in vitro Th2 responses. In vivo studies on a mouse model of Par j 1 sensitization indicate that the prophylactic intranasal treatment with probiotic bacteria is able to modulate the development of Th2-biased responses. (c) 2009 S. Karger AG, Basel.
Author information
Author/s: Mastrangeli, Giorgia (G); Corinti, Silvia (S); Butteroni, Cinzia (C); Afferni, Claudia (C); Bonura, Angela (A); Boirivant, Monica (M); Colombo, Paolo (P); Di Felice, Gabriella (G);
Affiliation: Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: International archives of allergy and immunology (Int Arch Allergy Immunol), published in Switzerland. (Language: eng)
Reference: 2009-; vol 150 (issue 2) : pp 133-43
Dates: Created 2009/09/17; Completed 2009/10/12;
PMID: 19439979, status: MEDLINE (last retrieved date: 10/12/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Allergens (0) ; Antigens, CD (0) ; GATA3 Transcription Factor (0) ; Gata3 protein, mouse (0) ; Immunoglobulins (0) ; Interleukin-13 (0) ; Interleukin-5 (0) ; Lipopolysaccharides (0) ; Par j I protein, Parietaria judaica (0) ; Plant Proteins (0) ; T-Box Domain Proteins (0) ; T-box transcription factor TBX21 (0) ; Interleukin-10 (130068-27-8) ; Interleukin-12 (187348-17-0) ; Interleukin-4 (207137-56-2) ; Interferon-gamma (82115-62-6)Related articles
These are the most related articles currently in our database:
- A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.
6 Mar 2007 - Interaction of Pneumocystis carinii with dendritic cells and resulting host responses to P. carinii.
30 Dec 2006 - Coating of cationized protein on engineered nanoparticles results in enhanced immune responses.
13 May 2002 - Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.
29 Apr 1998 - Pulmonary host defenses.
29 Sep 1998 - Immunohistochemistry.
30 Dec 1990 - Alcohol consumption alters antigen-specific Th1 responses: mechanisms of deficit and repair.
30 Jul 1998 - TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
16 Jul 2005 - Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice.
30 Jan 1998 - Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.
28 Feb 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.